Univ Paris Diderot, EA 3964 Laboratory, Sorbonne Paris Cité, France.
J Infect Dis. 2012 Nov;206(9):1399-406. doi: 10.1093/infdis/jis511. Epub 2012 Aug 28.
Emergence of quinolone-resistant Escherichia coli (QREC) is an increasing clinical challenge mostly originating in fecal microbiota. The dynamics of the emergence of QREC in feces from individuals exposed to ciprofloxacin is unknown.
A total of 48 healthy volunteers received oral ciprofloxacin for 14 days. Fecal specimens were collected on days 0, 8, 14, and 42. Subpopulations of QREC were detected on selective agar, genetically characterized, and compared with quinolone-susceptible E. coli (QSEC) strains collected on different days.
On day 42, 34 subjects carried QSEC, and 14 carried QREC. Of the 14 who carried QREC, 9 carried quinolone-susceptible E. coli on day 0, 1 carried E. coli with a lower level of quinolone resistance on day 0, and 4 carried E. coli with similar levels of resistance and RAPD-genotypes on days 0 and 42. No plasmid acquisition and no selection of resistant mutants from the initial microbiota was evidenced in any case.
In QREC emerging under ciprofloxacin pressure in the fecal microbiota, no proof of selection of quinolone-resistant mutants from the initial microbiota was evidenced, suggesting that QREC strains on day 42 were either present at undetectable levels in the initial microbiota or that exogenous acquisition of QREC strains occurred. Clinical Trials Registration. NCT00190151.
喹诺酮耐药大肠杆菌(QREC)的出现是一个日益严峻的临床挑战,主要起源于粪便微生物群。暴露于环丙沙星的个体粪便中 QREC 出现的动态变化尚不清楚。
共有 48 名健康志愿者接受了 14 天的口服环丙沙星治疗。在第 0、8、14 和 42 天采集粪便标本。在选择性琼脂上检测 QREC 亚群,对其进行基因特征分析,并与不同日期采集的喹诺酮敏感大肠杆菌(QSEC)菌株进行比较。
第 42 天,34 名受试者携带 QSEC,14 名携带 QREC。在携带 QREC 的 14 名患者中,9 名患者在第 0 天携带喹诺酮敏感的大肠杆菌,1 名患者在第 0 天携带较低水平的喹诺酮耐药大肠杆菌,4 名患者在第 0 天和第 42 天携带具有相似耐药水平和 RAPD 基因型的大肠杆菌。在任何情况下,均未发现质粒获得和从初始微生物群中选择耐药突变体的证据。
在粪便微生物群中受环丙沙星压力影响而出现的 QREC 中,未发现从初始微生物群中选择喹诺酮耐药突变体的证据,这表明第 42 天的 QREC 菌株要么在初始微生物群中处于无法检测的水平,要么外源性获得了 QREC 菌株。临床试验注册。NCT00190151。